Now online at AIDS Treatment News:

*** HIV Travel Restrictions: Where to Find Help Navigating Them
Here are places to look if you need to find out about HIV travel
restrictions and testing requirements of countries around the world.
For example, a database of all countries is now being maintained in
Europe, and made available through the Web in English, German, and
French.
Full article:
http://www.aidsnews.org/2005/04/travel-restrictions.html

***Tipranavir: FDA Advisory Committee Will Meet May 19, Hear Experts,
Public Comment
At a one-day public meeting in Gaithersburg, Maryland (near
Washington D.C.), the FDA will hear from experts and members of the
public on tipranavir, an important new protease inhibitor expected to
be approved soon.
Full article: http://www.aidsnews.org/2005/04/tipranavir-hearing.html

***Sculptra Facial Treatment: New Physician Locator
Dermik, the maker of Sculptra (a treatment for facial lipoatrophy,
called New Fill in some countries) has created a database to help
patients find physicians in their area who use the product. Our
announcement also points to information from the recent Retroviruses
conference on preventing the problem in the first place and avoiding
the need for the treatment, by switching antiretroviral regimens if
lipoatrophy starts to develop.
Full article: http://www.aidsnews.org/2005/04/sculptra-doctors.html

*** FDA AIDS Announcements, First Quarter 2005
Here are the eight announcements from the AIDS list serve of the
U.S. Food and Drug Administration, from January through March 2005.
Full article: http://www.aidsnews.org/2005/04/fda-announcements.html

*** Uganda Study Found That Death Reduced HIV Prevalence; Did the
Public Take Home the Wrong Message?
Uganda has had a remarkable decline in HIV prevalence, and the
question of what caused this decline is controversial. An intensive
study of the Rakai region of Uganda from 1994 - 2003 found that much of
the decreased prevalence resulted from death of people with HIV. But
the incidence of new HIV infections was low throughout this study and
did not change greatly, suggesting that the real cause of the success
was a large reduction in new infections before the study began. The
early data presented at the February 2005 Retroviruses conference also
showed increasing use of condoms, and some backsliding on reducing the
number of sexual partners. But neither change was big enough to greatly
affect the incidence of new infections, at least in the aggregate data
across the 50 villages studied. In summary, the big reduction in HIV
prevalence occurred because of changes that happened before this study,
not those measured within it. Therefore the new information does not
contradict reduction in the number of sexual partners as a major cause
of Uganda's success.
Full article: http://www.aidsnews.org/2005/04/uganda-rakai.html

*** Virginity Pledge Did Not Prevent Sexually Transmitted Infections
A major U.S. study of sexually transmitted diseases in young people
found that virginity pledges were associated with behaviors that would
seem to be protective, and yet had no benefit in preventing disease.
Full article: http://www.aidsnews.org/2005/04/virginity-pledges.html

*** Prison Health Care: New York Times Series Brings Attention
A three-part series and an editorial in The New York Times, the
result of a year's investigation, has brought attention to the bad
medical care in prisons in the U.S. -- deficiencies that kill prisoners
and allow epidemics to spread. The wrong funding arrangements,
incentives to make money by reducing care, and the huge growth in the
number of prisoners in the U.S. are major causes. We also comment on
shortage of social space as a potential root cause of prison and other
problems.
Full article: http://www.aidsnews.org/2005/04/prison-healthcare.html

--
John S James
AIDS Treatment News
www.aidsnews.org